KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,950,000 | +10.6% | 457,059 | 0.0% | 17.03% | -2.2% |
Q2 2022 | $8,999,000 | -53.5% | 457,059 | 0.0% | 17.42% | -41.7% |
Q1 2022 | $19,343,000 | -33.3% | 457,059 | 0.0% | 29.87% | -26.1% |
Q4 2021 | $29,019,000 | -22.7% | 457,059 | -28.5% | 40.42% | +66.9% |
Q3 2021 | $37,538,000 | +21.1% | 639,059 | 0.0% | 24.22% | +35.5% |
Q2 2021 | $30,994,000 | +24.8% | 639,059 | 0.0% | 17.87% | +90.8% |
Q1 2021 | $24,834,000 | -43.1% | 639,059 | -9.2% | 9.37% | -43.3% |
Q4 2020 | $43,652,000 | – | 704,059 | – | 16.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |